Right Drug Dose Now Act of 2024

[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 7848 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 7848 To update the National Action Plan for Adverse Drug Event Prevention to consider advances in pharmacogenomic research and testing, to improve electronic health records for pharmacogenomic information, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 29, 2024 Mr. Swalwell (for himself and Mr. Crenshaw) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To update the National Action Plan for Adverse Drug Event Prevention to consider advances in pharmacogenomic research and testing, to improve electronic health records for pharmacogenomic information, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Right Drug Dose Now Act of 2024''. SEC. 2. TABLE OF CONTENTS. The table of contents of this Act is as follows: Sec. 1. Short title. Sec. 2. Table of contents. Sec. 3. National Action Plan for Adverse Drug Event Prevention. Sec. 4. Adverse drug event and pharmacogenomic testing education for health care professionals. Sec. 5. Improving EHR systems to improve the use of pharmacogenomic information. SEC. 3. NATIONAL ACTION PLAN FOR ADVERSE DRUG EVENT PREVENTION. The Secretary of Health and Human Services (in this Act referred to as the ``Secretary'') shall-- (1) not later than 180 days after the date of enactment of this Act, in coordination with the heads of other relevant Federal departments and agencies, submit a report to the Congress on the implementation of the National Action Plan for Adverse Drug Event Prevention of the Department of Health and Human Services, including o